Piper Heartland Healthcare Capital
Overview
Piper Heartland Healthcare Capital is a private equity firm specializing in healthcare investments. It aligns the knowledge, expertise, and capital of Piper Sandler with the interests of its limited partners to invest in innovative healthcare companies at key moments in their growth path. This combination allows the firm to pursue proprietary investment opportunities and deliver exceptional potential returns for investors. The firm's flagship fund, the Piper Heartland Healthcare Crossover Fund, is a dedicated healthcare investment fund with over $200 million in committed capital. It focuses on innovative companies with near-term public market prospects, driven by experienced management teams and backed by highly respected investment partners. The fund primarily invests in biotech, med-tech, and healthcare information sectors, leveraging Piper Sandler's leading healthcare banking and research platforms. The firm has made several investments, including in companies like Kardium, OrganOx, AdvanCell, Saluda Medical, Alentis Therapeutics, Epic Bio, Alumis, ProfoundBio, Avalyn Pharma, Boundless Bio, Cargo Therapeutics, Metagenomi, Cleerly, Bicara Therapeutics, Structure Therapeutics, and Endeavor BioMedicines. The leadership team includes Matt Hemsley as CEO, Ahmad El Naggar as Director, Trent Holland as Vice President, and John Snodgrass as Associate.
Investment Focus
- Experienced management teams
- Near-term public market prospects
- Innovative healthcare companies
Portfolio Companies
Reach Piper Heartland Healthcare Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Piper Heartland Healthcare Capital
What sectors does Piper Heartland Healthcare Capital invest in?
Piper Heartland Healthcare Capital invests in Biotech, Healthcare Information Technology and Med-Tech, and is based in Minnesota, United States. Piper Heartland Healthcare Capital is listed as a private equity in the ConnectSafely investor database.
What stage does Piper Heartland Healthcare Capital invest at?
Piper Heartland Healthcare Capital backs companies at Early Stage, Growth, Late Stage, Pre-IPO and Buyout, writing cheques of 10M - 50M.
Which regions does Piper Heartland Healthcare Capital invest in?
Piper Heartland Healthcare Capital invests across United States, United Kingdom, Canada, Australia and Switzerland.
What companies has Piper Heartland Healthcare Capital invested in?
Piper Heartland Healthcare Capital's portfolio includes Bicara Therapeutics, ProfoundBio, Kardium, Alentis Therapeutics, OrganOx, AdvanCell, Saluda Medical and Epic Bio.
Last updated · Source: ConnectSafely investor database
